Tech Company Financing Transactions
Jupiter Endovascular Funding Round
On 10/7/2025, Jupiter Endovascular raised $40 million in Series B financing from Sonder, LB Investment and Senvest Capital.
Transaction Overview
Company Name
Announced On
10/7/2025
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to complete its ongoing SPIRARE II pivotal clinical trial, prepare for commercialization, and develop new clinical applications for its TFX platform technology.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
155 Jefferson Dr 100
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Where the precision and control of surgery could be combined with the safety and simplicity of catheter interventions. spanning the breadth of cardiovascular disease where we see compelling opportunities to reimagine therapies for millions of patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carl St. Bernard
Chief Scientific Officer
Chuck Love
VP - Manufacturing
Nihar Mankad
VP - Product Management
Garrett Gomes
VP - Product Management
Ben Hu
VP - Regulatory Affairs
Aadi Chachad
Browse more venture capital transactions:
Prev: 10/7/2025: Kadence venture capital transaction
Next: 10/7/2025: Figment venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs